United States· US:42023-105_6efcbde7-9a3d-4d12-93ea-793a9e72725a
Brevital Sodium
A medicinal product containing methohexital sodium, registered in United States by Par Health USA, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- METHOHEXITAL SODIUM
- Manufacturer
- Par Health USA, LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1142023105011 VIAL in 1 CARTON (42023-105-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
- ndc1142023-105-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Methohexital sodium in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyBrevimytalHikma Farmacêutica (Portugal), S.A.
- FinlandBrietalEli Lilly Finland Oy Ab
- United KingdomBrevital Sodium 500mg powder for solution for injection vialsImported (United States)
- NetherlandsBrietal Hikma, poeder voor injectievloeistof 500 mgHikma Farmaceutica (Portugal), S.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Austria · Brietal
- Germany · Brevimytal
- Netherlands · Brietal
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ba248763-62c8-451a-b9d6-79c64efa1675 GET /v1/drugs/ba248763-62c8-451a-b9d6-79c64efa1675?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAMUSCULAR; INTRAVENOUS; RECTAL",
"source": "ndc",
"strength": "500",
"substance": "METHOHEXITAL SODIUM",
"productndc": "42023-105",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"dea_schedule": "CIV",
"strength_unit": "mg/1",
"application_number": "NDA011559",
"marketing_category": "NDA"
}See everything about methohexital sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.